|
|
(3 intermediate revisions not shown.) |
Line 1: |
Line 1: |
| | | |
| ==Solution structure of micelle-bound aurein 1.2, an antimicrobial and anticancer peptide from an Australian frog== | | ==Solution structure of micelle-bound aurein 1.2, an antimicrobial and anticancer peptide from an Australian frog== |
- | <StructureSection load='1vm5' size='340' side='right'caption='[[1vm5]], [[NMR_Ensembles_of_Models | 5 NMR models]]' scene=''> | + | <StructureSection load='1vm5' size='340' side='right'caption='[[1vm5]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[1vm5]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VM5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1VM5 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[1vm5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VM5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1VM5 FirstGlance]. <br> |
- | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 5 models</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1o53|1o53]], [[1vm2|1vm2]], [[1vm3|1vm3]], [[1vm4|1vm4]]</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1vm5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1vm5 OCA], [http://pdbe.org/1vm5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1vm5 RCSB], [http://www.ebi.ac.uk/pdbsum/1vm5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1vm5 ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1vm5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1vm5 OCA], [https://pdbe.org/1vm5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1vm5 RCSB], [https://www.ebi.ac.uk/pdbsum/1vm5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1vm5 ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/AUR12_RANRN AUR12_RANRN] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 22: |
Line 24: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Li, X]] | + | [[Category: Synthetic construct]] |
- | [[Category: Wang, G]] | + | [[Category: Li X]] |
- | [[Category: Amphipathic helix]] | + | [[Category: Wang G]] |
- | [[Category: Antibacterial peptide]]
| + | |
- | [[Category: Antibiotic]]
| + | |
- | [[Category: Antitumor peptide]]
| + | |
- | [[Category: Micelle]]
| + | |
| Structural highlights
Function
AUR12_RANRN
Publication Abstract from PubMed
To understand the functional differences between a nontoxic membrane anchor corresponding to the N-terminal sequence of the Escherichia coli enzyme IIA(Glc) and a toxic antimicrobial peptide aurein 1.2 of similar sequence, a series of peptides was designed to bridge the gap between them. An alteration of a single residue of the membrane anchor converted it into an antibacterial peptide. Circular dichroism spectra indicate that all peptides are disordered in water but helical in micelles. Structures of the peptides were determined in membrane-mimetic micelles by solution NMR spectroscopy. The quality of the distance-based structures was improved by including backbone angle restraints derived from a set of chemical shifts ((1)H(alpha), (15)N, (13)C(alpha), and (13)C(beta)) from natural abundance two-dimensional heteronuclear correlated spectroscopy. Different from the membrane anchor, antibacterial peptides possess a broader and longer hydrophobic surface, allowing a deeper penetration into the membrane, as supported by intermolecular nuclear Overhauser effect cross-peaks between the peptide and short chain dioctanoyl phosphatidylglycerol. An attempt was made to correlate the NMR structures of these peptides with their antibacterial activity. The activity of this group of peptides does not correlate exactly with helicity, amphipathicity, charge, the number of charges, the size of the hydrophobic surface, or hydrophobic transfer free energy. However, a correlation is established between the peptide activity and membrane perturbation potential, which is defined by interfacial hydrophobic patches and basic residues in the case of cationic peptides. Indeed, (31)P solid state NMR spectroscopy of lipid bilayers showed that the extent of lipid vesicle disruption by these peptides is proportional to their membrane perturbation potential.
Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.,Wang G, Li Y, Li X J Biol Chem. 2005 Feb 18;280(7):5803-11. Epub 2004 Nov 30. PMID:15572363[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Wang G, Li Y, Li X. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J Biol Chem. 2005 Feb 18;280(7):5803-11. Epub 2004 Nov 30. PMID:15572363 doi:http://dx.doi.org/M410116200
|